Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Jacobs Solutions enters its Q2 FY2026 earnings — due May 5 — carrying its highest short interest in a month and a board-level governance change, against a backdrop of options markets that are actually turning less…
Jack in the Box heads into its May 13 earnings report with short sellers at their most aggressive in years, a stock down 12% on the week, and every analyst on the Street cutting targets rather than upgrading. The short…
JPMorgan Chase & Co. enters May carrying a rare internal signal: eight senior executives, including CEO Jamie Dimon, all sold shares on the same day. The stock closed the week at $309.25, down just over 1% on the week…
JTNB Bancorp is a small community bank holding company trading on the OTC Pink market, and the data available this week tells a limited story. The most recent reliable price is $19.90, recorded on March 31 — nearly a…
XIU, Canada's flagship large-cap index ETF, enters the final day of April with shorts at an elevated level but the borrow market sending an entirely different signal — one that suggests caution rather than conviction…
XBB, the iShares Core Canadian Universe Bond Index ETF, is sitting at a rare crossroads: borrowing costs have surged to a multi-month high just as the number of shares sold short has collapsed, producing an unusual…
XSB, the iShares Core Canadian Short Term Bond Index ETF, enters the final days of April with a dramatic re-set in short positioning — the most notable development on the tape in weeks. The standout story here is the…
Itron, Inc. enters the post-earnings window with the stock pricing in disappointment after a weaker-than-expected Q1 print and a fresh round of analyst target cuts. Q1 2026 results landed on April 28 and the market's…
ITEX Corporation has posted four straight weeks of modest gains, closing at $2.99 on April 29 — up roughly 5% on the week and around 5% over the past month. For a micro-cap OTC name with no analyst coverage and no…
IRIDEX Corporation enters its May 12 earnings window sitting at $1.03 — down 2% on the week — after one of the more dramatic short-selling episodes in its recent history. The most telling detail this month is not where…
IVRO is a micro-cap OTC stock trading at $0.0887. It gained 11% on the week to close Monday flat against its monthly pace. The most interesting angle here is not short positioning — it is the stock's consistent habit…
Centerspace enters its May 4 first-quarter report with a month-long rally, fresh analyst conviction, and a notable cluster of new institutional owners — a combination that makes the earnings print unusually…
Intrusion Inc. enters its May 12 Q1 earnings report with a striking reversal: short sellers who had aggressively built positions over April have now retreated almost entirely, even as the stock keeps falling. The…
INTU heads into its May 21 earnings call with short sellers meaningfully rebuilding positions — yet borrow conditions remain easy and the Street keeps its constructive stance well above the current price. The most…
InTest Corporation heads into its Q1 2026 earnings call — scheduled for May 4 — with options sentiment at its most bullish in months, the stock up sharply on a one-month view, and a cluster of insider selling in the…
Internet Initiative Japan heads into its May 14 full-year earnings print with a short-interest spike that arrived — and is already unwinding — in the same fortnight. The defining move this week was a dramatic rebuild…
PNPN enters the end of April on the back foot, down 14% on the week to CAD 1.08, yet the pullback is unfolding against a backdrop of retreating short interest — a split between price action and positioning that is…
Clean Energy Transition Inc. is a micro-cap mining name trading at CAD $0.04 — and this week's headline is a noisy-looking short interest figure that, on closer inspection, means almost nothing at all. Short interest…
PURE Bioscience heads into the final days of April trading near $0.069 — a stock that has lost roughly a fifth of its value over the past month, even as it clawed back about 5% this week. The price tells most of the…
Insmed Incorporated enters its May 7 Q1 results with a clear tension at its core: the Street is broadly bullish and price targets sit well above where the stock trades, yet short sellers have been quietly rebuilding…
